Abstract | BACKGROUND: MATERIALS AND METHODS: An analysis of 66 pediatric patients (range, 1-19 years of age) with glioblastoma multiforme (GBM) (n=40) or anaplastic astrocytoma (AA) (n=26) was retrospectively conducted for predictors of survival and response and for effects of VPA on outcome or toxicity. RESULTS: The overall survival (OS) was better for AA (p=0.0114) and complete resection (p<0.00005) and event-free survival (EFS) was better for complete resection (p=0.0049). Nine patients received VPA (for seizure) plus further oncological treatment. The most severe adverse effect was a pulmonary embolism (n=1); no other severe side-effects were noted. The response to nonsurgical treatment after 8 weeks was: complete response (CR): 0, partial response (PR): 3, stable disease (SD): 4, progressive disease (PD): 2. Some of the patients with SD responded later resulting in best response: CR:0, PR:5, SD:2, PD:2. CONCLUSION: Treatment with VPA plus radiochemotherapy is well tolerated with an encouraging response rate.
|
Authors | Amirhadi Masoudi, Marily Elopre, Elham Amini, Margaret E Nagel, Joann L Ater, Vidya Gopalakrishnan, Johannes E A Wolff |
Journal | Anticancer research
(Anticancer Res)
2008 Jul-Aug
Vol. 28
Issue 4C
Pg. 2437-42
ISSN: 0250-7005 [Print] Greece |
PMID | 18751431
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Astrocytoma
(drug therapy, surgery)
- Child
- Child, Preschool
- Disease-Free Survival
- Female
- Glioblastoma
(drug therapy, surgery)
- Humans
- Infant
- Male
- Retrospective Studies
- Valproic Acid
(adverse effects, therapeutic use)
|